Abstract
One of the most important changes in the treatment of patients with diabetes mellitus type 2 with oral agents are „New guidelines for DM type 2“, which were prepared of IDF, EASD and ADA. Treatment strategy is changing with emphasis on the early starting of farmacological treatment with metformin as an agent of „first choice“.